Position of Subcutaneous Implantable Cardioverter-Defibrillators and Possible Interference on Myocardial Perfusion Imaging
- PMID: 28761406
- PMCID: PMC5505404
- DOI: 10.14503/THIJ-16-5921
Position of Subcutaneous Implantable Cardioverter-Defibrillators and Possible Interference on Myocardial Perfusion Imaging
Abstract
Implanted cardioverter-defibrillators can prevent sudden cardiac death in at-risk patients. In comparison with conventional transvenous systems, entirely subcutaneous implantable cardioverter-defibrillators have produced similar reductions in the rate of sudden cardiac death but with fewer sequelae. An infrequently reported drawback of subcutaneous devices, however, is the potential for generating attenuation artifact during nuclear myocardial perfusion imaging. We had concerns about potential attenuation artifact in a 65-year-old man with coronary artery disease but found that having positioned the pulse generator in the midaxillary zone avoided problems.
Keywords: Arrhythmias, cardiac/therapy; artifacts; coronary artery disease/diagnostic imaging; death, sudden, cardiac/prevention & control; defibrillators, implantable; equipment safety; myocardial perfusion imaging/methods.
Figures





Similar articles
-
Implantable Cardioverter-Defibrillators and Wearable Defibrillators: Guidelines and Updates.Tex Heart Inst J. 2020 Feb 1;47(1):51-52. doi: 10.14503/THIJ-19-7030. eCollection 2020 Feb. Tex Heart Inst J. 2020. PMID: 32148457 Free PMC article. No abstract available.
-
Recent developments in the subcutaneous ICD.Trends Cardiovasc Med. 2016 Aug;26(6):526-35. doi: 10.1016/j.tcm.2016.03.004. Epub 2016 Mar 15. Trends Cardiovasc Med. 2016. PMID: 27079889 Review.
-
Ventricular fibrillation undersensing due to air entrapment in a patient implanted with a subcutaneous cardioverter defibrillator.J Cardiovasc Electrophysiol. 2019 Aug;30(8):1373-1374. doi: 10.1111/jce.14005. Epub 2019 Jun 20. J Cardiovasc Electrophysiol. 2019. PMID: 31165543 No abstract available.
-
Continuous ST-Monitoring Function of Implantable Cardioverter Defibrillator Detects Silent Ischemia in Patients With Coronary Artery Disease.J Am Heart Assoc. 2018 Jun 30;7(13):e009332. doi: 10.1161/JAHA.118.009332. J Am Heart Assoc. 2018. PMID: 29960992 Free PMC article.
-
Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.Circ Arrhythm Electrophysiol. 2014 Apr;7(2):337-46. doi: 10.1161/CIRCEP.113.000371. Circ Arrhythm Electrophysiol. 2014. PMID: 24736423 Review. No abstract available.
Cited by
-
Myocardial perfusion imaging in patients with subcutaneous implantable cardioverter defibrillators: Is this the correct test?J Nucl Cardiol. 2023 Aug;30(4):1713-1716. doi: 10.1007/s12350-022-03016-2. Epub 2022 Jun 8. J Nucl Cardiol. 2023. PMID: 35676549 No abstract available.
References
-
- Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M, . et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 2013; 128 9: 944– 53. - PubMed
-
- Burke MC, Gold MR, Knight BP, Barr CS, Theuns DA, Boersma LV, . et al. Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry. J Am Coll Cardiol 2015; 65 16: 1605– 15. - PubMed
-
- Rowley CP, Gold MR.. Subcutaneous implantable cardioverter defibrillator. Circulation Arrhythm Electrophysiol 2012; 5 3: 587– 93. - PubMed
-
- Katz JS, Rajper N, Giedd KN.. SPECT attenuation artifact in a patient with a subcutaneous implantable cardioverter-defibrillator. J Nucl Cardiol 2015; 22 6: 1326– 8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical